Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.
OBJECTIVE
To assess the relative risk of perinatal mortality, severe preterm delivery, and low birth weight associated with previous treatment for precursors of cervical cancer.


METHODS
Medline and Embase citation tracking from January 1960 to December 2007. Selection criteria Eligible studies had data on severe pregnancy outcomes for women with and without previous treatment for cervical intraepithelial neoplasia. Considered outcomes were perinatal mortality, severe preterm delivery (<32/34 weeks), extreme preterm delivery (<28/30 weeks), and low birth weight (<2000 g, <1500 g, and <1000 g). Excisional and ablative treatment procedures were distinguished.


RESULTS
One prospective cohort and 19 retrospective studies were retrieved. Cold knife conisation was associated with a significantly increased risk of perinatal mortality (relative risk 2.87, 95% confidence interval 1.42 to 5.81) and a significantly higher risk of severe preterm delivery (2.78, 1.72 to 4.51), extreme preterm delivery (5.33, 1.63 to 17.40), and low birth weight of <2000 g (2.86, 1.37 to 5.97). Laser conisation, described in only one study, was also followed by a significantly increased chance of low birth weight of <2000 g and <1500 g. Large loop excision of the transformation zone and ablative treatment with cryotherapy or laser were not associated with a significantly increased risk of serious adverse pregnancy outcomes. Ablation by radical diathermy was associated with a significantly higher frequency of perinatal mortality, severe and extreme preterm delivery, and low birth weight below 2000 g or 1500 g.


CONCLUSIONS
In the treatment of cervical intraepithelial neoplasia, cold knife conisation and probably both laser conisation and radical diathermy are associated with an increased risk of subsequent perinatal mortality and other serious pregnancy outcomes, unlike laser ablation and cryotherapy. Large loop excision of the transformation zone cannot be considered as completely free of adverse outcomes.
Arbyn
M
M
Scientific Institute of Public Health, Brussels, Belgium. Marc.Arbyn@iph.fgov.be
Kyrgiou
M
M
Simoens
C
C
Raifu
A O
AO
Koliopoulos
G
G
Martin-Hirsch
P
P
Prendiville
W
W
Paraskevaidis
E
E
D005260:Female; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000209:etiology* / Q000401:mortality; D013513:Obstetric Surgical Procedures / Q000009:adverse effects* / Q000401:mortality; D054238:Perinatal Mortality; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000401:mortality / Q000601:surgery*; D011256:Pregnancy Outcome; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000601:surgery*; D002578:Uterine Cervical Dysplasia / Q000401:mortality / Q000601:surgery*
N Engl J Med. 1995 Dec 28;333(26):1737-42
7491137
Clin Perinatol. 1995 Jun;22(2):281-342
7671540
BMJ. 1998 Oct 31;317(7167):1185-90
9794851
Cytopathology. 1999 Jun;10(3):161-70
10390064
BMJ. 2005 Nov 19;331(7526):1183-5
16293840
Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S7-11
16154623
Lancet. 2006 Feb 11;367(9509):489-98
16473126
Int J Cancer. 2006 Apr 15;118(8):2048-55
16284947
Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89
16950021
BJOG. 2007 Jan;114(1):3-4
17233854
J Perinat Med. 2007;35(1):5-9
17313304
Acta Obstet Gynecol Scand. 2007;86(5):596-603
17464590
BJOG. 2007 Jun;114(6):775-6; author reply 776-7
17516977
BMJ. 2007 Nov 24;335(7629):1077
17959735
Int J Gynaecol Obstet. 2008 Jan;100(1):24-6
17897647
Acta Oncol. 2000;39(1):71-5
10752657
Cochrane Database Syst Rev. 2000;(2):CD001318
10796771
Obstet Gynecol. 2001 May;97(5 Pt 1):643-8
11339909
JAMA. 2002 Apr 24;287(16):2120-9
11966387
Eur J Obstet Gynecol Reprod Biol. 2002 Apr 10;102(1):88-91
12039097
Gynecol Oncol. 2002 Jul;86(1):10-3
12079292
Stat Med. 2002 Jun 15;21(11):1601-23
12111922
BMJ. 2003 Sep 6;327(7414):557-60
12958120
Obstet Gynecol. 2003 Nov;102(5 Pt 1):1058-62
14672487
J Natl Cancer Inst. 2004 Feb 18;96(4):280-93
14970277
Cancer Treat Rev. 2004 Apr;30(2):205-11
15023438
Stat Med. 2004 May 15;23(9):1351-75
15116347
JAMA. 2004 May 5;291(17):2100-6
15126438
Ugeskr Laeger. 1979 Dec 17;141(51):3509-11
538846
Acta Obstet Gynecol Scand. 1986;65(3):199-202
3090849
Control Clin Trials. 1986 Sep;7(3):177-88
3802833
Br J Obstet Gynaecol. 1987 Feb;94(2):168-72
3828256
N Engl J Med. 1988 Jun 30;318(26):1728-33
3374545
Br J Obstet Gynaecol. 1989 Sep;96(9):1054-60
2804007
Obstet Gynecol. 1990 Dec;76(6):1009-13
2234708
Obstet Gynecol. 1993 Jun;81(6):1005-8
8497340
Br J Obstet Gynaecol. 1993 Nov;100(11):1059-60
8251459
Obstet Gynecol. 1997 Dec;90(6):978-82
9397115